Menu

HomeConferencesCollectionsCalls for PapersMSF Research EthicsClinical Case ReportingAboutMy Saved Content
Logo

Science Portal

  • My Saved Content
  • Browse All
  • Conferences
  • Collections
  • Calls for Papers
  • MSF Research Ethics
  • Clinical Case Reporting
  • About
English
logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.prod.produswest2
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.prod.produswest2
Conference Material
|Video

Real-world evidence on uptake and persistent use of long-acting injectable Cabotegravir (CAB-LA) offered as HIV prevention alternative in female sex work hotspots, Malawi

O'Regan C
Similar Content
Abstract
|Abstract
Real-world evidence on uptake and persistent use of long-acting injectable Cabotegravir (CAB-LA) offered as HIV prevention alternative in female sex work hotspots, Malawi
2026 June 04 • Epicentre Scientific Day 2026
Loading...
Loading...
Video in English

Countries

Malawi

Subject Area

women's healthHIV/AIDS

Languages

English
Published Date
04 Aug 2026
Conference
Epicentre Scientific Day 2026
Linked Content
Conference Material
|Abstract
Real-world evidence on uptake and persistent use of long-acting injectable Cabotegravir (CAB-LA) offered as HIV prevention alternative in female sex work hotspots, Malawi
2026 June 04 • Epicentre Scientific Day 2026
Real-world evidence on uptake and persistent use of long-acting injectable Cabotegravir (CAB-LA) offered as HIV prevention alternative in female sex work hotspots, Malawi | Conference Material / Video | MSF Science Portal